HPS Pharmacies wish to give notice that Amdipharm Mercury Australia is experiencing a supply interruption for cyclizine ampoules as follows:
Cyclizine lactate 50mg/1mL
Normal supplies are expected to resume in late December 2019. An internationally registered brand of cyclizine lactate 50mg/1mL injection ampoules is now available under Section 19A of the Therapeutic Goods Act 1989. Please note that Section 19A alternatives are subject to a longer lead time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Amdipharm Mercury Australia on (02) 9431 6333, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates